Cargando…

Expression of four cancer-testis antigens in TNBC indicating potential universal immunotherapeutic targets

OBJECTIVE: Immunotherapy is an attractive treatment for breast cancer. Cancer-testis antigens (CTAs) are potential targets for immunotherapy for their restricted expression. Here, we investigate the expression of CTAs in breast cancer and their value for prognosis. So as to hunt for a potential pane...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Jie, Huang, Fengli, Li, Lin, Zhang, Lianru, Xie, Li, Liu, Baorui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602960/ https://www.ncbi.nlm.nih.gov/pubmed/37610673 http://dx.doi.org/10.1007/s00432-023-05274-0

Ejemplares similares

Identification of potential immunotherapeutic targets in antigen presentation and costimulation networks
por: Spaapen, Robbert, et al.
Publicado: (2014)

The Potential of PSMA as a Vascular Target in TNBC
por: Heesch, Amelie, et al.
Publicado: (2023)

Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects()
por: Wei, Xiao, et al.
Publicado: (2019)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma
por: Zhang, Yao, et al.
Publicado: (2014)

Recent Progress on Therapeutic Vaccines for Breast Cancer
por: Zhang, Lianru, et al.
Publicado: (2022)

Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers
por: Ai, Huihan, et al.
Publicado: (2023)

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential
por: Naik, Adviti, et al.
Publicado: (2021)

LptD is a promising vaccine antigen and potential immunotherapeutic target for protection against Vibrio species infection
por: Zha, Zhenzhong, et al.
Publicado: (2016)

Targeting cancer testis antigens in synovial sarcoma
por: Mitchell, Geoffrey, et al.
Publicado: (2021)

TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
por: Singh, Desh Deepak, et al.
Publicado: (2021)

Immunotherapeutic strategies targeting B cell maturation antigen in multiple myeloma
por: Fang, Yi, et al.
Publicado: (2021)

Gene-based cancer-testis antigens as prognostic indicators in hepatocellular carcinoma
por: Xu, Yingyu, et al.
Publicado: (2023)

GE11-antigen-loaded hepatitis B virus core antigen virus-like particles efficiently bind to TNBC tumor
por: Zhang, Long, et al.
Publicado: (2023)

Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
por: Tan, Renbo, et al.
Publicado: (2020)

Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target
por: Xu, Hao, et al.
Publicado: (2020)

Optimization of Short RNA Aptamers for TNBC Cell Targeting
por: Camorani, Simona, et al.
Publicado: (2022)

An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC
por: Zhang, Mengqi, et al.
Publicado: (2023)

Macrophages as a Potential Immunotherapeutic Target in Solid Cancers
por: Mishra, Alok K., et al.
Publicado: (2022)

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
por: Xie, Kaipeng, et al.
Publicado: (2019)

Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review)
por: Ren, Shengnan, et al.
Publicado: (2023)

Identification of the prognostic and immunotherapeutic potential of L antigen family member 3 in malignant pleural mesothelioma
por: Dong, Xubin, et al.
Publicado: (2020)

Immunotherapeutic Potential of T Memory Stem Cells
por: Li, Yujie, et al.
Publicado: (2021)

PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD
por: Dong, Penggang, et al.
Publicado: (2023)

Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy
por: Shim, Kyeonghee, et al.
Publicado: (2023)

Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target
por: Koni, Malvina, et al.
Publicado: (2022)

Cancer testis antigen and immunotherapy
por: Krishnadas, Deepa Kolaseri, et al.
Publicado: (2013)

SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma
por: Shan, Qingqing, et al.
Publicado: (2023)

Potential Immunotherapeutic Targets on Myeloid Cells for Neurovascular Repair After Ischemic Stroke
por: Zhu, Ziyu, et al.
Publicado: (2019)

sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatment
por: Huang, Ying, et al.
Publicado: (2017)

In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors
por: Sun, Zhichen, et al.
Publicado: (2022)

Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens
por: Aruga, Atsushi
Publicado: (2013)

Leukemia Associated Antigens: Their Dual Role as Biomarkers and Immunotherapeutic Targets for Acute Myeloid Leukemia
por: Guinn, Barbara-ann, et al.
Publicado: (2007)

Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens
por: Luo, Yong, et al.
Publicado: (2020)

Computational screen to identify potential targets for immunotherapeutic identification and removal of senescence cells
por: Deng, Eden Z., et al.
Publicado: (2023)

STING signaling is a potential immunotherapeutic target in colorectal cancer
por: Chon, Hong Jae, et al.
Publicado: (2019)

Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer
por: Hirani, Priyanka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6prk06jqhuvm0pkr14dn25gg3m